Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Saven

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemiaA Saven, R H Lemon, M Kosty, et al.
Blood|September 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphomaA Saven, S Emanuele, M Kosty, et al.
Blood|August 1, 1992
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphomaA Saven, C J Carrera, D A Carson, et al.
Cancer Treatment and Research|January 1, 1993
Hairy cell leukemia: new understanding of biology and treatmentA Saven, L D Piro, C J Carrera, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaA Saven, C J Carrera, D A Carson, et al.
Annals of Internal Medicine|July 1, 1993
Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a modelK A Foon, R Thiruvengadam, A Saven, et al.
Leukemia & Lymphoma|June 1, 1996
New perspectives on the approach to chronic lymphocytic leukemiaM G Goodman, J C Spinosa, A Saven, et al.
Blood|September 1, 1991
Enzyme replacement therapy for Gaucher diseaseE Beutler, A Kay, A Saven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemiaA Saven, T Lee, M Schlutz, et al.
Mayo Clinic Proceedings|October 1, 1996
Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemiaT C Lee, W E Miller, J G Curd, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemiaA Saven, R H Lemon, M Kosty, et al.
Blood|September 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphomaA Saven, S Emanuele, M Kosty, et al.
Blood|August 1, 1992
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphomaA Saven, C J Carrera, D A Carson, et al.
Cancer Treatment and Research|January 1, 1993
Hairy cell leukemia: new understanding of biology and treatmentA Saven, L D Piro, C J Carrera, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaA Saven, C J Carrera, D A Carson, et al.
Annals of Internal Medicine|July 1, 1993
Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a modelK A Foon, R Thiruvengadam, A Saven, et al.
Leukemia & Lymphoma|June 1, 1996
New perspectives on the approach to chronic lymphocytic leukemiaM G Goodman, J C Spinosa, A Saven, et al.
Blood|September 1, 1991
Enzyme replacement therapy for Gaucher diseaseE Beutler, A Kay, A Saven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemiaA Saven, T Lee, M Schlutz, et al.
Mayo Clinic Proceedings|October 1, 1996
Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemiaT C Lee, W E Miller, J G Curd, et al.
Pageof 7